Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
European Heart Journal
Abstract
The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.
Contributors
Petr Kuchynka
Author
Marco Merlo
Author
Yehuda Adler
Author
Chiara Bucciarelli Ducci
Author
Matteo Cameli
Author
Lia Crotti
Author
Lorenzo Dagna
Author
Andrea Frustaci
Author
Allan Klein
Author
Johanna Kuusisto
Author
Angela Lopez Sainz
Author
Renzo Marcolongo
Author
Antonis Pantazis
Author
Angelos G Rigopoulos
Author
Arsen Ristic
Author
Petar Seferovic
Author
Mary Sheppard
Author
Carsten Tschöpe
Author
Thomas Lüscher
Author
Royal Brompton and Harefield NHS Foundation Trust London , United Kingdom of Great Britain & Northern Ireland
You may be interested in
